Efficacy of internal administration of Tilakanda Kshara in the management of benign prostatic hyperplasia- A pre-post study
DOI:
https://doi.org/10.70066/jahm.v13i1.1539Abstract
Background: Benign Prostatic Hyperplasia (BPH) is a prevalent, non-cancerous tumour affecting aging men, significantly contributing to lower urinary tract symptoms (LUTS) worldwide. This condition substantially impacts quality of life. Prevalence of histologic BPH with age is approximately 20% (41-50 years), 50% (51-60 years), and over 90% (above 80 years). Treatment modalities span from conservative management (watchful waiting) to Medical therapy and Surgical intervention. According to Ayurvedic texts, Mutra rogas' severity manifests as vibhanda (obstruction), predominantly observed in Mutraghata. While no single disease mirrors Benign Prostatic Hyperplasia (BPH) exactly, Mutragranthi, described under Mutraghata, shares striking similarities. Objectives: To evaluate the efficacy of internal administration of tilakanda kshara in the management of Benign Prostatic Hyperplasia. Materials and methods: This is a single group pre- post interventional study conducted on 20 participants from OPD and IPD department of salya tantra, Govt Ayurveda College, Thiruvananthapuram. Participants diagnosed with BPH was subjected to internal administration of kshara for a period of 30 days. Conclusion: A majority of the participants experienced significant relief from symptoms of BPH, even though there was no statistically significant reduction in prostate size. Furthermore, the post-void residual urine volume showed a significant reduction in most participants, both clinically and statistically. Therefore, it can be concluded that the internal administration of Tila Kanda Kshara with Dadhi Mastu is both clinically and statistically effective and can be considered a viable approach for the management of BPH.
References
Infante Hernández S, Gómez Rivas J, Moreno Sierra J. Benign prostatic hyperplasia. Med Clin (Barc). 2024 Oct 25;163(8):407–14.
. Ng M, Leslie SW, Baradhi KM. Benign Prostatic Hyperplasia. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Sep 6]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK558920
K R Srikantha Murthy (editor) Susrutha Samhita of susrutha, Utaratantra volume III, chapter 58 verses no.18-19, Varanasi, Chaukambha Orientalia,reprinted edition 2017 : 382.
K R Srikantha Murthy(editor) Susrutha Samhita of Susrutha, Utaratantra volume III, chapter 58 verses12, Varanasi, Chaukambha Orientalia,reprinted edition 2017: 382.
K R Srikantha Murthy(editor), Ashtanga hrudyam of vagbhata Sutrasthana chapter10 verses 27 ,Varanasi,Chaukambha Krishnadas Academy; reprinted edition 2014: 44
pandey jaimini. ( editor) Hareetha samhitha chikilsa sthana; vol. one varanasi: choukamba vishwa bharathi.
Wein AJ, Kavoussi LR, Partin AW, Peters CA,Campbell-Walsh urology. Wein AJ, Kavoussi LR, Partin AW, Peters CA editors Eleventh edition. Philadelphia, PA: Elsevier; 2016: 2441
Wein AJ, Kavoussi LR, Partin AW, Peters CA, Campbell-Walsh urology. Wein AJ, Kavoussi LR, Partin AW, Peters CA editors Eleventh edition. Philadelphia, PA: Elsevier; 2016:2442.
Shivalingappa J Arakeri, Shidlingaiah Hiremanthada , Mohasin Kadegoan , Ashwani Hallad A Review Article on Utility of Paneeya Kshara in Surgical Diseases. Int J MultidisciplinaryReasearch 2023 Jan 16
Prakash . l hegde, harini A. A Text Book of Dravyaguna Vijnana. Revised edition 2020. Chaukhambha Publications; 2014.
Harikumar KB, Sung B, Tharakan ST, Pandey MK, Joy B, Guha S, et al. Sesamin manifests chemopreventive effects through the suppression of NF-kappa B-regulated cell survival, proliferation, invasion, and angiogenic gene products. Mol Cancer Res MCR. 2010 May;8(5):751–61.
Additional Files
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 angel litty kt Kurishingal house

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors retain the copyright of their work and grant the Journal of Ayurveda and Holistic Medicine (JAHM) the right of first publication. All published articles are licensed under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) license, which permits non-commercial sharing, use, distribution, and adaptation with proper attribution and the same license terms.
JAHM ensures free, irrevocable, worldwide access to its content. Users may copy, distribute, display, and share published works for non-commercial purposes with appropriate credit to the author(s) and the journal. Limited printed copies for personal, non-commercial use are allowed under the same license.
If a submission is not accepted for publication, the author(s) will be notified.
By submitting, authors confirm that the work is original, that all listed authors have contributed and approved it, and that it does not infringe any third-party rights or duplicate work submitted elsewhere.